Silexon is an AI drug research and development service provider. It is committed to the systematic integration of drug big data using artificial intelligence methods, and deep-enhanced drug development process, specifically involving drug target panorama report, personalized cell therapy, and small molecule virtual screening.
TechnologiesAI Companies (Drug Discovery)
Silexon has 4 various AI models for virtual high-throughput screening and Drug-Target interaction/affinity predictions.
No pipelines published yet
No services posted yet